MYCN and acute myeloid leukemia: In the DEG profiling of AML-NK patients, about 72% (n = 18/25) of the genes that were reported in AML studies were overexpressed in the DX samples that included several oncogenes (FLT3, MYB, DNMT3B, and MYCN).